• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Esperite (Group)

Cryo-Save, the leading international family stem cell bank, already stores 175,000 samples from cord blood and umbilical cord tissue for newborns and adipose tissue for adults. These stem cells can mean the difference between life and death in the case of future threats to the health of the donors. There are already several diseases that can be cured by the use of stem cells, and the number of treatments will only increase. Driven by its international business strategy, Cryo-Save is now represented in 40 countries on three continents, with ultra-modern processing and storage facilities in Belgium, Germany, Dubai, India and France (validation in progress). *

 

	Start	2014-07-02 renamed
	Predecessor	Cryo-Save (Group)
	Industry	BIOTECH
	Industry 2	stem cell bank
	Person	Amar, Frédéric (Esperite 201801 CEO)
	Region	Netherlands_oo
	Country	Netherlands
Basic data	Employees	D: 101 to 500 (2012-12-31)
	Currency	EUR
	Annual sales	36,842,000 (revenue (2012) 2012-12-31)
	Profit	-17,103,000 (2012-12-31)
	Cash	7,088,000 (2012-12-31)
		* Document for �About Section�: Cryo-Save Group N.V.. (5/10/11). "Press Release: Cryo-Save Group N.V. – Revenue Up 8% to EUR10.4 Million and Operating Profit Up 53% to EUR1.3 Million".
		Record changed: 2018-02-08

Advertisement

More documents for Esperite (Group)

• [1] Esperite N.V.. (1/31/18). "Press Release: Esperite (ESP) and BGI Genomics (BGI) Sign a Strategic Agreement to Offer Whole Genome Sequencing on a Large Scale". Amsterdam....
• [2] Premaitha Health plc. (5/12/17). "Press Release: Update Re. Swiss Customer". Manchester....
• [3] Illumina, Inc.. (4/21/16). "Press Release: Illumina Files Patent Infringement Suit in Switzerland against Genoma SA for Infringement of NIPT Patents". San Diego, CA....
• [4] Cryo-Save Group N.V.. (3/19/13). "Press Release: 2012 Results Impacted by Non-recurring Impairments, Restructuring Costs and the Implementation of Cost Saving Programs". Zutphen....
• [5] Cryo-Save Group N.V.. (3/20/12). "Press Release: Cryo-Save Group N.V. – Revenue up 4% to €41.9 Million". Zutphen....
• [6] Cryo-Save Group N.V.. (3/20/12). "Presentation: Financial Results 2011. Arnoud van Tulder – Chief Executive Officer". Zutphen....
• [7] Cryo-Save Group N.V.. (6/2/11). "Press Release: Cryo-Save and Lazaron Biotechnologies Establish Stem Cell Bank Joint Venture in South Africa"....
• [8] Cryo-Save Group N.V.. (5/17/11). "Press Release: Announcement of Milestone Payment for Storing Umbilical Cord Tissue in Serbia and Launch in Switzerland"....
• [9] Cryo-Save Group N.V.. (5/10/11). "Press Release: Cryo-Save Group N.V. – Revenue Up 8% to EUR10.4 Million and Operating Profit Up 53% to EUR1.3 Million"....
• [10] Cryo-Save Group N.V.. (2/3/11). "Press Release: Acquisition of Serbian Distributor"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.